miRNAs role in bladder cancer pathogenesis and targeted therapy: Signaling pathways interplay – A review
- 20 January 2023
- journal article
- review article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 242, 154316
Abstract
No abstract availableKeywords
This publication has 200 references indexed in Scilit:
- Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancerBritish Journal of Cancer, 2011
- MicroRNA-1826 targets VEGFC, beta-catenin (CTNNB1) and MEK1 (MAP2K1) in human bladder cancerCarcinogenesis, 2011
- miR‐92 is a key oncogenic component of the miR‐17–92 cluster in colon cancerCancer Science, 2011
- The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancerBritish Journal of Cancer, 2011
- miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancerBritish Journal of Cancer, 2010
- MicroRNA-125b is a novel negative regulator of p53Genes & Development, 2009
- Target mimicry provides a new mechanism for regulation of microRNA activityNature Genetics, 2007
- A microRNA component of the p53 tumour suppressor networkNature, 2007
- c-Myc-regulated microRNAs modulate E2F1 expressionNature, 2005
- ERBB receptors and cancer: the complexity of targeted inhibitorsNature Reviews Cancer, 2005